Log on / register
Feedback | Support | My details
Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled type 2 diabetes in the United Kingdom.
Woehl A, Evans M, Tetlow AP, McEwan P
Cardiovasc Diabetol 2008, 7:24
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Incretin-based therapies: new treatments for type 2 diabetes in the new millennium.
Khoo J, Rayner CK, Jones KL, Horowitz M
Ther Clin Risk Manag 2009 Jun, 5:683-98
 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 1 article in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.